Roberto Chiarle

35PUBLICATIONS
209CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsTumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Aug 18, 2026
PASTA: versatile tyramide-oligonucleotide amplification for multimodal spatial biology.

|Jul 28, 2026
CD4+ T cells orchestrate the immune response to ALK-positive T-cell lymphoma.

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Jan 30, 2026
Evaluation of the Role of AID-Induced Mutagenesis in Resistance to B-Cell Receptor Pathway Inhibitors in Chronic Lymphocytic Leukemia.

Chiara Pighi, Alessandro Gasparetto, Elisa Genuardi

|Dec 24, 2025
Exportin 1 as a Therapeutic Target to Overcome Drug Resistance in Lung Cancer.

Maria Vittoria Di Marco, Alessandro Gasparetto, Roberto Chiarle

|Oct 08, 2025
CAR-ving a Path: Metalloprotease-Engineered CAR T Cells Tunnel through Solid Tumors.

Alessandro Gasparetto, Roberto Chiarle

Pageof 6

Frequent Collaborators

11 joint publications

Claudia Voena

9 joint publications

Chiara Ambrogio

7 joint publications

Taek-Chin Cheong

4 joint publications

Rafael B Blasco